» Articles » PMID: 35010703

Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy

Overview
Publisher MDPI
Date 2022 Jan 11
PMID 35010703
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinopathy has recently been defined as a highly specific neurovascular complication of diabetes. The chronic progression of the impairment of the interdependence of neurovascular units (NVUs) is associated with the pathogenesis of diabetic retinopathy. The NVUs consist of neurons, glial cells, and vascular cells, and the interdependent relationships between these cells are disturbed under diabetic conditions. Clinicians should understand and update the current knowledge of the neurovascular impairments in diabetic retinopathy. Above all, neuronal cell death is an irreversible change, and it is directly related to vision loss in patients with diabetic retinopathy. Thus, neuroprotective and vasoprotective therapies for diabetic retinopathy must be established. Understanding the physiological and pathological interdependence of the NVUs is helpful in establishing neuroprotective and vasoprotective therapies for diabetic retinopathy. This review focuses on the pathogenesis of the neurovascular impairments and introduces possible neurovascular protective therapies for diabetic retinopathy.

Citing Articles

Vitamin D Deficiency as a Risk Factor for Diabetic Retinopathy: A Systematic Review and Meta-Analysis.

Petrea C, Ghenciu L, Iacob R, Stoicescu E, Sandesc D Biomedicines. 2025; 13(1).

PMID: 39857652 PMC: 11762121. DOI: 10.3390/biomedicines13010068.


Stem Cell-Derived Exosomes: Natural Intercellular Messengers with Versatile Mechanisms for the Treatment of Diabetic Retinopathy.

Song Y, Yin C, Kong N Int J Nanomedicine. 2024; 19:10767-10784.

PMID: 39469447 PMC: 11514697. DOI: 10.2147/IJN.S475234.


Resveratrol Protects Müller Cells Against Ferroptosis in the Early Stage of Diabetic Retinopathy by Regulating the Nrf2/GPx4/PTGS2 Pathway.

Wang Y, Song S, Song Y, Wang Y, Wan Z, Sun P Mol Neurobiol. 2024; 62(3):3412-3427.

PMID: 39292340 DOI: 10.1007/s12035-024-04496-8.


Targeting pericyte retention in Diabetic Retinopathy: a review.

Bohler F, Bohler L, Taranikanti V Ann Med. 2024; 56(1):2398200.

PMID: 39268600 PMC: 11404372. DOI: 10.1080/07853890.2024.2398200.


Different Types of Cell Death in Diabetic Neuropathy: A Focus on Mechanisms and Therapeutic Strategies.

Ye S, Cheng Z, Zhuo D, Liu S Int J Mol Sci. 2024; 25(15).

PMID: 39125694 PMC: 11311470. DOI: 10.3390/ijms25158126.


References
1.
Oshitari T, Nonomura S, Arai M, Takatsuna Y, Sato E, Baba T . Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microaneurysm photocoagulation on diabetic macular edema. Int Med Case Rep J. 2015; 8:321-6. PMC: 4676612. DOI: 10.2147/IMCRJ.S89970. View

2.
Moschos M, Dettoraki M, Tsatsos M, Kitsos G, Kalogeropoulos C . Effect of carotenoids dietary supplementation on macular function in diabetic patients. Eye Vis (Lond). 2017; 4:23. PMC: 5641400. DOI: 10.1186/s40662-017-0088-4. View

3.
Pannicke T, Iandiev I, Wurm A, Uckermann O, Vom Hagen F, Reichenbach A . Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes. 2006; 55(3):633-9. DOI: 10.2337/diabetes.55.03.06.db05-1349. View

4.
. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98(5 Suppl):786-806. View

5.
Bogdanov P, Sola-Adell C, Hernandez C, Garcia-Ramirez M, Sampedro J, Simo-Servat O . Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice. J Diabetes Complications. 2017; 31(10):1481-1490. DOI: 10.1016/j.jdiacomp.2017.07.009. View